Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04930666 · ClinicalTrials.gov registry record
BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 30
- Enrollment target
NCT04930666 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 30 participants.
The verdict
NCT04930666 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study aims to: 1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers 2. To evaluate the feasibility and acceptability of intervention procedures; and 3. To explore intervention effects on ALD outcomes
Interventions
- OTHER BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2025-02-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04930666
The ClinicalTrials.gov registry entry for NCT04930666 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease is the first listed.
NCT04930666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04930666 about?
NCT04930666 is a clinical study titled "BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease". This study aims to: 1. Develop the BREATHE-ALD intervention for adults with Advanced Lung Disease, multiple chronic conditions, and palliative care needs and their caregivers using interviews with 10 advanced lung disease (ALD) adults and their caregivers 2. To evaluate the feasibility and acceptab...
What is the current status of trial NCT04930666?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-11-10. Estimated completion is 2025-02-06.
What interventions are being tested in trial NCT04930666?
The interventions under investigation include: BRief intervention to Enhance Adherence to Treatment and HEalth advice in Advanced Lung Disease (OTHER).
Who is sponsoring clinical trial NCT04930666?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.